FIGURE 7.

KS18 is safe and inhibits MM tumor growth. (A), MM xenograft was developed as described in Materials and Methods section. Mice were treated with increasing dose of KS18 once a week for 4 weeks. (B), KS18 dosages were delivered for 28 days in xenografted mice, with animal weights (g) recorded weekly. (C), the graph depicts tumor volume (mm³) in mice treated with either vehicle or KS18. Mean ± SEM of animal body weight (g) and tumor volume (mm³) for vehicle (DMSO) and KS18-treated mice, presented using GraphPad Prism.